Caris & Co. Upgrades Covidien Ltd (COV) to Buy
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Caris & Co. upgraded Covidien Ltd (NYSE: COV) from Above Average to Buy, maintains price target of $64.00.
For more ratings news on Covidien Ltd click here and for the rating history of Covidien Ltd click here.
Shares of Covidien Ltd closed at $47.06 yesterday.
For more ratings news on Covidien Ltd click here and for the rating history of Covidien Ltd click here.
Shares of Covidien Ltd closed at $47.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades Cochlear Ltd. (COH:AU) to Neutral
- TD Cowen Upgrades BRP Inc. (DOOO) to Buy
- Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
